Read More

为什么以色列和特朗普应该支持巴勒斯坦建国

(SeaPRwire) - 几个国家,包括美国、加拿大和澳大利亚,已宣布将效仿法国总统埃马纽埃尔·马克龙,在下个月的联合国大会期间承认巴勒斯坦国。这一发展代表着一个有意义的转变,有助于为解决以巴冲突创造新动力,同时削弱哈马斯和其他圣战组织所宣扬的暴力抵抗意识形态。更多主要西方国家应加入承认巴勒斯坦国的行列。 当然,两国并存的愿景并非新生事物。1947年,联合国投票决定为两个民族——一个犹太民族,一个阿拉伯民族——建立两个国家,但需遵守一系列条件。阿拉伯领导人拒绝了分治计划,而以色列则在不久后成立。迄今为止,在193个联合国成员国中,有147个国家承认巴勒斯坦,其中114个与巴勒斯坦权力机构保持着全面的外交关系。然而,尽管公开支持“两国方案”,大多数主要西方民主国家直到最近才承认巴勒斯坦。 巴勒斯坦解放组织(PLO),作为国际公认的巴勒斯坦人民代表,早在1988年就承认了以色列的生存权——这一承认在奥斯陆进程中得到重申,并被纳入《阿拉伯和平倡议》中。相比之下,以色列从未承认过巴勒斯坦国,即使在表面上旨在实现这一结果的谈判中也未曾承认。正是这种不平衡,法国发起的、以色列政府反对的这一举动开始着手解决。 主要西方国家所创造的外交势头可能成为一个转折点。它将使它们走在全球共识的前沿,这一共识已体现在联合国安理会第242号和第338号决议、《奥斯陆协议》、2002年《阿拉伯和平倡议》以及唐纳德·特朗普总统的2020年中东和平计划中。令人遗憾的是,特朗普政府驳回了这些国家的主张。 作为爱国的以色列人,我们认为“两国两民方案”仍然是以色列人和巴勒斯坦人实现和平与长期安全的唯一可行途径。以色列不应本能地拒绝法国的外交倡议,而应更好地利用它以及随后的声明来增强以色列的国家安全和国际地位。 我们欢迎日益增长的国际承认,原因如下: 第一,它向双方极端分子传递了一个强有力的信息:对整片土地拥有排他性主权的极端主义愿景是不合法的,也不会得到国际社会的认可。 第二,这一承认提供了一个建设性的意识形态制衡,以对抗哈马斯和其他圣战组织。仅靠军事行动无法击败极端主义;它必须与一个可信的、替代性的政治愿景相结合。承认巴勒斯坦为国,提供了一条和平且现实的道路,它削弱了暴力抵抗的叙事,并给寻求建立巴勒斯坦国的巴勒斯坦人带来了希望。因此,一旦替代方案成为现实,它必将加强巴勒斯坦社会内部的温和力量,边缘化极端分子,并提高安全性。同时,以色列应保持对其自身安全的责任,并继续其打击哈马斯和其他圣战组织的斗争。 第三,承认巴勒斯坦国对未来的谈判具有影响——特别是在巴勒斯坦难民这一有争议的问题上。一个得到承认的巴勒斯坦国为难民的接纳和安置提供了明确的解决方案,有助于解决冲突中最复杂和最情感化的一个方面。 第四,这种提前承认可以促成以色列人和巴勒斯坦人之间明确边界的建立,这有助于增强各自国家的安全。一旦边界划定...

泽连斯基携欧洲领导人团队重返白宫:你需要了解的

(SeaPRwire) -本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。泽连斯基自今年早些时候与特朗普发生争执以来,首次重返椭圆形办公室。这一次,他带来了援军。

Read More

NEC and ClimateAi Develop Conceptual Model to Promote Climate Change Adaptation in Agriculture

Tokyo, Japan, August 19, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701), in collaboration with ClimateAi, a San Francisco-based startup that built the first climate resilience platform, has developed a conceptual model to estimate the effectiveness of climate change adaptation measures for cocoa and rice cultivation in Africa. In this project, ClimateAi’s long-term climate change forecasting technology, which models both the impact of climatic factors on agricultural production and the effectiveness of adaptation measures, was combined with NEC’s expertise in agricultural technology (agritech) to successfully quantify the impact of climate change on agriculture and clarify the return on investment for adaptation measures.This achievement will be showcased at the TICAD Business Expo & Conference (Japan Fair), one of the thematic events of the Ninth Tokyo International Conference on African Development (TICAD 9) to be held in Yokohama, Japan, in August 2025, conveying the significance of utilizing digital technology to address the challenges facing African agriculture (*1).Background and purposeGlobally, while greenhouse gas emission r...

Read More

Value Research Center to host The Valuism Conference 2025 on August 28-29 (Hybrid Format)

KYOTO, August 19, 2025 - ACN Newswire via SeaPRwire.com - The Value Research Center at Doshisha University proudly announces The Valuism Conference 2025, taking place August 28–29, 2025, in a hybrid format, both in-person in Kyoto and online. The conference will run daily from 9:00 AM to 6:00 PM JSTA New Framework for Value CreationThis inaugural Valuism gathering aims to advance a novel integrative framework, Valuism, designed to address pressing challenges in sustainability, long-term resilience, and multi-stakeholder value creation. Attendees will explore how philosophical insight, cutting-edge technologies (e.g., AI, blockchain, big data), and cross-sector collaboration can foster transparency, ethical decision-making, and real-time measurement of value.Featuring keynote speeches, expert panels, and interactive sessions, The Valuism Conference 2025 will cover:- Philosophical foundations and real-world applications of Valuism Strategies for monetizing and scaling intangible assets - The role of emerging technologies in sustainable and ethical business practices- Cross-sector approaches that benefit companies, communities, shareholders, employees, and the environment.Regist...

Read More

Fujitsu signs new licensing agreement with Palantir

Kawasaki, Japan, August 19, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the signing of a new licensing agreement with Palantir Technologies Japan for the Palantir Artificial Intelligence Platform (Palantir AIP), a software that supports the integration of generative AI into business operations. The agreement, signed on August 5, 2025, will allow Fujitsu to provide Palantir AIP to its customers in Japan, with global expansion expected during fiscal 2025. Fujitsu will also combine Palantir AIP with Fujitsu Uvance, its business model to solve societal issues, to facilitate business transformation for its customers in Japan and around the world. This agreement will further strengthen the strategic global partnership between Fujitsu and Palantir.Fujitsu and Palantir began their collaboration in 2020, focusing on data integration and digital transformation support in the Japanese market. In 2023, the two parties signed a global agreement, under which Palantir grants Fujitsu the right to market and distribute Palantir Foundry, a platform currently offered for integrated management of large-scale data dispersed across various systems.When combined with Palantir F...

Read More

2025年最值得关注的AI股票

(SeaPRwire) - 随着人工智能 (AI) 继续重塑全球各行各业,投资者正密切关注 AI 领域的机遇。AI 被整合到从医疗保健到金融,甚至娱乐等各个领域,其增长潜力巨大。有效利用 AI 的公司很可能实现显著增长,使其成为对投资者有吸引力的前景。 AI 领域的一个重要参与者是 NVIDIA (NASDAQ:NVDA)。NVIDIA 以其尖端图形处理单元 (GPU) 而闻名,已成为 AI 开发的基石。其 GPU 对于为需要强大计算能力的 AI 应用(如深度学习和神经网络)提供动力至关重要。随着 AI 的不断发展,NVIDIA 的作用预计会越来越大,使其成为值得关注的关键股票。 另一家处于 AI 创新前沿的公司是 Alphabet (NASDAQ:GOOGL),它是 Google 的母公司。Alphabet 对 AI 的投入体现在其采用机器学习的各种产品和服务中,从搜索算法到自动驾驶汽车技术。该公司在 AI 研发方面的投资使其成为该领域的领导者,并有望为投资者带来可观的长期回报。 此外,Microsoft (NASDAQ:MSFT) 也在 AI 领域取得了显著进展,利用其 Azure 云平台为企业提供 AI 服务。Microsoft 的 AI 解决方案旨在帮助企业自动化流程、从数据中获取洞察并提升客户体验。凭借其强大的市场地位和持续创新,Microsoft 对于对 AI 股票感兴趣的投资者来说仍然是一个引人注目的选择。 AI 行业的特点是快速发展和竞争激烈的格局。能够迅速创新和适应的公司很可能取得成功。这给投资者带来了机遇和风险,因为市场可能难以预测。将投资分散到多只 AI 股票中可以减轻其中一些风险,同时使投资者能够利用该行业的增长潜力。 展望未来,在自动化、数据分析和提高各行业效率的需求推动下,对 AI 技术的需求预计将增加。认识到 AI 变革力量并投资于该领域领先公司的投资者,可能会随着这些技术日益融入日常生活而获得显著回报。 Footnotes: 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 NVIDIA 的 GPU 对于需要高计算能力的 AI 应用至关重要。 Alphabet 的 AI 投资涵盖从搜索算法到自动驾驶技术。 Microsoft 的 Azure 平台为企业自动化和洞察提供 AI 解决方案。

Read More

巴菲特出售苹果和银行股

(SeaPRwire) - 传奇投资者、Berkshire Hathaway首席执行官沃伦·巴菲特(Warren Buffett)以其经常影响市场趋势的战略性投资决策而闻名。最近有消息称,巴菲特正在减持在两家主要公司——Apple Inc.和Bank of America的股份。此举在金融界引起了广泛关注,因为这两家公司多年来一直是Berkshire Hathaway投资组合的重要组成部分。 作为巴菲特投资基石之一的Apple Inc.(NASDAQ:AAPL),在过去十年中股价一路飙升。该公司的创新产品和强大的品牌忠诚度使其成为投资者青睐的对象。然而,巴菲特决定出售部分这家科技巨头的股票,表明其投资策略发生了转变。虽然这一决定的确切原因尚未公开披露,但分析师猜测可能与估值过高或希望分散Berkshire Hathaway的持股有关。 同样,Bank of America(NYSE:BAC)作为巴菲特的另一项重要投资,在金融领域一直表现稳定。巴菲特对该银行的信心在他金融危机期间增持股份时显而易见,这有助于稳定该机构。然而,最近的抛售表明,在不断变化的经济格局中,巴菲特正在重新评估该银行的未来前景。利率上升和监管变化等因素可能正在影响巴菲特的决定。 值得注意的是,巴菲特的投资理念围绕长期价值。他通常投资于基本面强劲、具有竞争优势的公司。因此,他决定出售Apple和Bank of America的股票并不一定意味着对它们未来表现缺乏信心。相反,这可能反映了他认为当前市场状况在其他地方提供了更好的机会。 投资者密切关注巴菲特的举动,经常将其作为自己投资策略的指导。他减持这些股份的决定可能会促使其他投资者重新评估他们在类似股票中的头寸。然而,重要的是要记住,巴菲特的行为是基于他独特的视角和广泛的分析,这可能不符合每位投资者的目标。 随着市场对这一消息做出反应,巴菲特决定的更广泛影响将逐步显现。这是否预示着剥离科技和金融股的更广泛趋势,还是仅仅是对其投资组合的战略性再平衡,仍有待观察。投资者在根据巴菲特的举动做出任何决定之前,应仔细考虑自己的投资目标并进行彻底的研究。 总而言之,沃伦·巴菲特决定出售Apple Inc.和Bank of America的股份,凸显了投资策略的动态性。虽然这些公司在其各自行业中仍然是强大的参与者,但巴菲特的行动提醒我们,即使是最成功的投资者也会不断重新评估其投资组合,以适应不断变化的市场条件。 脚注: 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、...

Read More

高风险电动汽车股票机会

(SeaPRwire) - 电动汽车(EV)领域是一个充满活力且快速发展的行业,为投资者提供了众多机会。尽管老牌企业主导市场,但仍存在高风险、高回报的机会,有望带来可观的回报。其中一个机会是投资 Rivian Automotive (NASDAQ:RIVN),这是一家以其创新的电动汽车方法吸引了许多人想象力的公司。 Rivian,作为电动汽车市场的新兴参与者,已将自己定位为 Tesla 和其他老牌品牌的直接竞争对手。该公司以其电动卡车和SUV而闻名,迎合了环保意识消费者这一利基但不断增长的细分市场。Rivian 的 R1T 和 R1S 车型因其设计和性能而受到赞扬,兼具豪华和实用性,吸引了冒险爱好者和环保意识买家。 尽管前景看好,投资 Rivian 并非没有风险。该公司仍处于生产初期,与许多初创公司一样,它面临着扩大运营和实现盈利的挑战。电动汽车市场竞争激烈,传统汽车制造商和新进入者都在争夺市场份额。此外,供应链中断和原材料价格波动可能会影响生产时间表和成本,给 Rivian 的增长轨迹增添了另一层复杂性。 使 Rivian 成为一项引人注目的投资的关键因素之一是其来自主要投资者的强大支持。Amazon 和 Ford 已对 Rivian 进行了大量投资,不仅提供了资金支持,还提供了战略合作伙伴关系。尤其是 Amazon,已向 Rivian 订购了大量电动送货车,这可以提供稳定的收入来源,并帮助该公司在商用汽车领域站稳脚跟。 Rivian 对可持续发展和创新的关注与全球向绿色技术的转变高度契合。该公司已承诺建设强大的充电网络,并计划扩大其产品线,这可能会增强其竞争优势。随着全球各国政府实施更严格的排放法规,对电动汽车的需求预计将上升,可能惠及像 Rivian 这样的公司。 对于投资者而言,投资 Rivian 的决定取决于他们的风险承受能力和投资期限。尽管获得可观回报的潜力很诱人,但与一家年轻、快速增长的公司相关的固有风险不容忽视。投资者应进行彻底的尽职调查,在做出投资决定之前,考虑市场趋势、财务状况和竞争定位等因素。 总之,Rivian Automotive (NASDAQ:RIVN) 代表了电动汽车领域一个高风险、高回报的投资机会。其创新产品、战略合作伙伴关系和对可持续发展的承诺使其为未来增长奠定了良好基础。然而,投资者必须权衡这些因素与该公司在竞争激烈且快速变化的市场中所面临的挑战。 脚注: 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等...

Read More

Shuangdeng Group Proposed Listing on the Main Board of the Hong Kong Stock Exchange

HONG KONG, Aug 18, 2025 - (ACN Newswire via SeaPRwire.com) - Global leading storage battery company in data center and telecom industries – Shuangdeng Group Co., Ltd. (stock code: 06960.HK), proposes to list its H Shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”).Shuangdeng Group plans to offer 58,557,000 H Shares (subject to the Over-allotment Option), of which 52,701,000 H Shares will be International Offer Shares (subject to reallocation and the Over-allotment Option), representing approximately 90% of the initial offer shares; the remaining 5,856,000 H Shares will be Hong Kong Offer Shares (subject to reallocation), representing approximately 10% of the initial offer shares. The Offer Price is HK$14.51 per H Share, plus brokerage of 1.0%, SFC transaction levy of 0.0027%, Hong Kong Stock Exchange trading fee of 0.00565% and AFRC transaction levy of 0.00015% (payable in full on application in Hong Kong dollars and subject to refund).Shuangdeng Group will open for Hong Kong Public Offering in Hong Kong at 9 a.m., August 18, 2025 (Monday), and close at 12:00 noon, August 21, 2025 (Thursday). Dealings in H shares of Shuangdeng Group...

Read More

CENTRESTAGE 10th anniversary set to dazzle in September

- Some 260 brands from 24 countries and regions set to participate, a new high for the event, with the UK debuting as Partner Country to present works by leading British designers- Internationally acclaimed couturier Guo Pei will stage her first solo couture show in Hong Kong, unveiling 30 meticulously crafted pieces under the theme “Gilternity: An Everlasting Radiance”- Aligning with market trends, the fair will introduce a new Accessories Zone and will once again feature the Circular Fashion Zone to promote the development of sustainable fashion- The Fashion Hong Kong Runway Show will celebrate the creative journey of local brands; around 30 fashion shows will be staged during the fair – the highest number in the event’s historyHONG KONG, Aug 18, 2025 - (ACN Newswire via SeaPRwire.com) - Organised by the Hong Kong Trade Development Council (HKTDC) and sponsored by the Cultural and Creative Industries Development Agency (CCIDA) of the Government of the Hong Kong Special Administrative Region (HKSAR), CENTRESTAGE – the annual gala event for the Asian fashion industry – takes place from 3 to 6 September 2025 at the Hong Kong Convention and Exhibition Centre (HKCEC). Unveiling a gran...

Read More

The 35th Food Expo and concurrent fairs attract over 500,000 visits

- The Food Expo, Food Expo PRO, Hong Kong International Tea Fair, Beauty & Wellness Expo, and Home Delights Expo successfully concluded today, bringing together approximately 1,890 exhibitors and welcoming over 500,000 visits.- The per capital spending across the five fairs reached HK$1,630.- 48% of respondents believe that health, green and organic food trends are worth paying attention to. Halal food and beverage label at the expo helps promote the development of halal foods.- The five theme days, along with a series of exciting activities effectively boosted local consumption and created a bustling atmosphere.- The International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM) featured 21 prominent speakers who shared innovative achievements and development trends in the globalisation of Chinese medicine.HONG KONG, Aug 18, 2025 - (ACN Newswire via SeaPRwire.com) - Organised by the Hong Kong Trade Development Council (HKTDC), the Food Expo, Beauty & Wellness Expo, and Home Delights Expo successfully concluded today. Food Expo PRO and the Hong Kong International Tea Fair, which opened to both industry professionals and the public for the firs...

Read More

斩获12金14银11铜 摘得大满贯!首程控股多家被投企业闪耀世界人形机器人运动会

香港,2025年8月18日 - (亚太商讯 via SeaPRwire.com) - 2025 年8月17 日,全球首个以人形机器人为核心参赛主体的大型综合性赛事——世界人形机器人运动会,在北京国家速滑馆"冰丝带"圆满落幕。本届运动会由北京市人民政府、中央广播电视总台、世界机器人合作组织、亚太机器人世界杯国际理事会等单位联合主办,集聚全球 280 支战队、500 余台机器人同台竞技,展现了具身智能机器人从技术突破走向场景应用的完整产业链条。在本次大会中,首程控股(0697.HK)作为深度产业推动者,多家被投企业集体亮相,参与多个重点项目并获得优异成绩,共计斩获37枚奖牌,其中包括12金14银11铜(包括各战队使用被投企业本体机器人参赛获奖情况)。与此同时,首程控股还在"冰丝带"外场打造了面向公众开放的"首程机器人科技体验店",成为大会期间最受关注的互动展区之一。一、多家被投企业集结亮相本次赛事首程控股本次参展的多家企业涵盖了人形机器人本体、底层技术平台、零部件能力与具身智能生态的多个核心环节:宇树科技:在 2025 世界人形机器人运动会圆满落幕之际,宇树科技以出色的表现获得了四金,再次证明了其在全球人形机器人领域的技术领先地位。宇树科技的机器人在多个项目中表现卓越,分别夺得1500米、400米、100米障碍赛和 4×100米接力赛的金牌,展现了其在速度、灵活性和稳定性方面的强大实力。此外,在本届赛事中,宇树科技的机器人最高速度达到了 4.78m/s,这一成绩距离其内部测试的 5+m/s 还有一定差距,未来在速度和灵活性方面仍有巨大的提升空间。基于宇树科技 G1 硬件平台开发的独立参赛队伍也取得了不俗成绩,分别获得了1金1银1铜,进一步验证了宇树科技平台的广泛适应性与强大性能。北京人形机器人创新中心:在2025世界人形机器人运动会上,北京人形机器人创新中心展现了卓越的技术实力和广泛的场景适应能力,累计斩获2金6银2铜,成为本届赛事最具代表性的"全自主执行"技术方之一。在竞技赛部分,其打造的"天工 Ultra"机器人是 1500 米比赛中唯一全程自主奔跑、无遥控介入的选手,最终获得银牌;在 100 米项目中夺得金牌,在 400 米项目中拿下银牌与铜牌各一枚,并在 4×100 米接力赛中获得银牌,全面展示了其在复杂运动控制、节奏协调与导航算法方面的领先优势。在场景赛中,创新中心自主研发的天轶 2.0 机器人,凭借慧思开物"具身大脑+具身小脑"的智能协同体系,在"物料整理"项目中包揽金银牌,在"物料搬运"项目中斩获银牌与铜牌,并在"酒店迎宾服务技能竞赛"中收获银牌。这些项目均要求高度精细化操作与复杂场景适应能力,充分体现了其在"自主感知-智能决策-精准执行"完整闭环中的技术突破。作为本届赛事中"全自主"能力最突出的参赛单位,北京人形机器人创新中心不仅实现了从实验室走...

Read More

美国特使接近达成黎巴嫩-以色列停火,有望解除真主党恐怖组织武装

(SeaPRwire) -   美国驻黎巴嫩特使汤姆·巴拉克周一表示,在他的团队与以色列讨论停火协议的可能性之后,贝鲁特已支持一项由美国支持的解除真主党恐怖组织武装的计划。巴拉克在与黎巴嫩总理纳瓦夫·萨拉姆的会晤后也表示,在数月的美黎穿梭外交之后,华盛顿将寻求一项针对该国战后重建的经济提案。真主党自1997年被美国正式认定为外国恐&#24598...

Read More

Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games

HONG KONG, Aug 18, 2025 - (ACN Newswire via SeaPRwire.com) - On August 17, 2025, the inaugural World Humanoid Robot Games—an international event centered on humanoid robots—concluded successfully at the National Speed Skating Oval in Beijing, also known as the “Ice Ribbon.”Co-hosted by the Beijing Municipal Government, China Media Group, the World Robot Cooperation Organization, and the Asia-Pacific RoboCup Council, the Games gathered 280 teams and over 500 robots from around the globe to compete across 26 disciplines, showcasing the full industrial chain from technological breakthroughs to real-world applications in embodied intelligence.As a key industrial accelerator, Shoucheng Holdings (0697.HK) saw several of its portfolio companies participate in major events, collectively winning 37 medals (12 gold, 14 silver, and 11 bronze), including awards where teams utilized robots built by Shoucheng’s portfolio firms. Simultaneously, Shoucheng launched the "Shoucheng Robot Tech Experience Store" adjacent to the venue, which became one of the most visited tech exhibits of the event.Highlights from Portfolio Companies:Unitree Robotics captured 4 gold medals and achieved a top speed of 4....

Read More

2025年最值得关注的AI股票

(SeaPRwire) -   随着人工智能 (AI) 继续重塑全球各行各业,投资者正密切关注 AI 领域的机遇。AI 被整合到从医疗保健到金融,甚至娱乐等各个领域,其增长潜力巨大。有效利用 AI 的公司很可能实现显著增长,使其成为对投资者有吸引力的前景。 AI 领域的一个重要参与者是 NVIDIA (NASDAQ:NVDA)。NVIDIA 以其尖端图形处理单元 (GPU) 而闻名,已成为 AI 开发的基石。其 GPU 对于为需要强大计&#...

Read More

Anime Tokyo Station Surpasses 200,000 Visitors

TOKYO, Aug 18, 2025 - (JCN Newswire via SeaPRwire.com) - Anime Tokyo Station, an exhibition center for Japanese anime operated by the Tokyo Metropolitan Government and the Association of Japanese Animations, is a facility that promotes the appeal of Japanese anime to the world under the motto “Making ANIME more interesting, Bringing ANIME far into the future.” The facility has welcomed numerous visitors from Japan and overseas, and on August 3, 2025, the number of visitors surpassed 200,000.The 200,000th visitors were a group of three from Fukuoka and Kanagawa Prefectures, and they shared their surprise and delight: “Today we happened to pass by Anime Tokyo Station and decided to come in because we love anime. We didn’t know this facility existed. We’re surprised to be here at such a commemorative moment—celebrating the 200,000th visitor.” When asked about which exhibits left an impression on them, they commented, “We were amazed to see the anime production materials archive and the anime production process exhibits on the first basement floor. It really hit us that anime is something that is actually created by people. It’s incredible.”Anime Tokyo Station preserves approximately 5...

Read More

Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China

TOKYO, August 18, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the in-house discovered and developed orexin receptor antagonist DAYVIGO® (brand name in China: “DAYVIGO®“ generic name: lemborexant) has launched in China for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. Eisai received approval for DAYVIGO in China on May 27, 2025. This marks the first orexin receptor antagonist to be launched in China.DAYVIGO is a dual orexin receptor antagonist that inhibits orexin neurotransmission regulating sleep-wake rhythm by binding competitively to the two subtypes of orexin receptors (OX1R and OX2R). Unlike conventional treatments such as benzodiazepines that act directly on sleepiness, DAYVIGO acts on the orexin neurotransmitter system, which regulates wakefulness. DAYVIGO is believed to facilitate sleep on set and sleep maintenance, and wake by regulating sleep-wake rhythm by suppressing hyperactive wakefulness. DAYVIGO binds to orexin receptors OX1R and OX2R and acts as a competitive antagonist with stronger inhibition effect on OX2R, which s...

Read More

The 35th Food Expo and concurrent fairs attract over 500,000 visits

HONG KONG, Aug 18, 2025 - (ACN Newswire via SeaPRwire.com) - Organised by the Hong Kong Trade Development Council (HKTDC), the Food Expo, Beauty & Wellness Expo, and Home Delights Expo successfully concluded today. Food Expo PRO and the Hong Kong International Tea Fair, which opened to both industry professionals and the public for the first time, wrapped up successfully on 16 August. The five exhibitions featured some 1,890 exhibitors and attracted over 500,000 visits. The bustling atmosphere resulted in a per capita spending of HK$1,630, once again demonstrating the appeal of this annual event and the public’s purchasing power. Over at Food Expo PRO and the Hong Kong International Tea Fair, there were some 18,500 buyers from 64 countries and regions. Apart from Hong Kong, buyers came from Mainland China, Japan, Korea, Taiwan, as well as ASEAN countries, including Cambodia, Malaysia, the Philippines, Thailand, and Vietnam, among others, highlighting Hong Kong's significant role as a key food trade hub globally. Additionally, the International Conference of the Modernization of Chinese Medicine and Health Products, or...

Read More

Sino Biopharm (1177.HK) Announces 2025 Interim Results

Development Highlights- During the reporting period, the Group had two innovative products approved for marketing by the NMPA, namely Putanning (Meloxicam Injection (II)) and Anqixin (Recombinant Human Coagulation Factor VIIa N01 for Injection).- In the first half of 2025, the Group’s sales of innovative products reached RMB7.8 billion, a year-on-year increase of 27.2%. In addition to innovative products, the Group had 5 generic drugs approved for marketing by the NMPA. The overall revenue of generic drugs achieved positive growth in the first half of 2025.- As of 30 June 2025, the Group had a total of 37 innovative drug candidates in the field of oncology, 7 innovative drug candidates related to liver/metabolic diseases, 13 innovative drug candidates related to the respiratory, and 6 innovative drug candidates in the field of surgery/analgesia in the process of clinical trial application or above. Of these, 2 innovative oncology drug candidates and 1 innovative surgery/analgesia drug candidate are in the marketing application stage, and 11 innovative oncology drug candidates, 1 innovative liver/metabolic diseases drug candidate, 3 innovative respiratory system drug candidate...

Read More

中国生物制药(1177.HK)公布2025中期业绩

重点成果- 期内,集团共有2个创新产品获中国国家药品监督管理局(「NMPA」)批准上市,分别为普坦宁(美洛昔康注射液(II))和安启新(注射用重组人凝血因子VIIa N01)。- 2025年上半年,集团创新产品收入达到人民币78亿元,同比增长27.2%。除创新产品外,集团还有5个仿制药获NMPA批准上市,整体仿制药收入在2025年上半年保持正增长。- 截至2025年6月30日,集团共&#2637...